Browsing: Eli
jetcityimage/iStock Editorial via Getty Images Eli Lilly (NYSE:LLY) has raised expectations for its experimental weight loss pill, orforglipron, capitalizing $548.1M…
Andrew Harnik/Getty Images NewsObesity drugmakers Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) have found themselves in two contrasting positions as…
FloortjeMajor stock indexes closed lower on Friday, after the week saw a flurry of corporate earnings reports from major tech…
Rimma_Bondarenko/iStock via Getty ImagesEli Lilly (NYSE:LLY) shares sold off on Tuesday after the Indiana-based pharma giant’s Q4 and 2024 preliminary…
Terminator3D/iStock via Getty ImagesBlockbuster weight loss medications from Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) lead Evaluate Pharma’s list of…
CRNovo Nordisk (NVO) and Eli Lilly (LLY), the undisputed leaders in the global obesity drug market, saw their stocks heading…